glooko.comHealthcare / Other HealthcareFounded: 2010Funding to Date: $521.83MM
Glooko is a healthcare technology company which offers a diabetes management platform to healthcare providers, patients, and pharmaceutical companies. The platform is designed to integrate with hundreds of diabetes devices to gather and analyze patient data. Through comprehensive data centralization and analytical tools, Glooko aims to enhance diabetes management and facilitate clinical research in the field. This company was founded by Yogen Dalal, Sundeep Madra, and Chamath Palihapitiya in 2010 and is headquartered in Palo Alto, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/10/2024 | Series F | $100MM | $xx.xx | $475.64MM | Canaan, Georgian Partners, Health Catalyst Capital | |
Price per Share
$xx.xx
Shares Outstanding
41,407,867
Liquidation Pref Order
1
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan, Georgian Partners, Health Catalyst Capital
|
||||||
08/18/2023 | Series E-Prime | $30.56MM | $xx.xx | $318.34MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,652,982
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/18/2023 | Series E | $30.56MM | $xx.xx | $318.34MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
12,652,982
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/16/2021 | Series D-Prime | $10MM | $xx.xx | $150.67MM | Canaan Partners, Georgian, Health Catalyst Capital, Insulet, Mayo Clinic, Novo Nordisk | |
Price per Share
$xx.xx
Shares Outstanding
7,510,886
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Georgian, Health Catalyst Capital, Insulet, Mayo Clinic, Novo Nordisk
|
||||||
03/16/2021 | Series D | $20MM | $xx.xx | $150.67MM | Canaan Partners, Georgian, Health Catalyst Capital, Insulet, Mayo Clinic, Novo Nordisk | |
Price per Share
$xx.xx
Shares Outstanding
15,021,772
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Georgian, Health Catalyst Capital, Insulet, Mayo Clinic, Novo Nordisk
|
||||||
06/27/2017 | Series C-1-Prime | $13.01MM | $xx.xx | $116.76MM | Canaan Partners, Georgian Partners, Insulet, Mayo Clinic, Medtronic, Samsung, Social Capital | |
Price per Share
$xx.xx
Shares Outstanding
10,335,930
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Georgian Partners, Insulet, Mayo Clinic, Medtronic, Samsung, Social Capital
|
||||||
06/27/2017 | Series C-1 | $13.29MM | $xx.xx | $116.76MM | Canaan Partners, Georgian Partners, Insulet, Mayo Clinic, Medtronic, Samsung, Social Capital | |
Price per Share
$xx.xx
Shares Outstanding
10,562,032
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Georgian Partners, Insulet, Mayo Clinic, Medtronic, Samsung, Social Capital
|
||||||
09/17/2016 | Series C-Prime | $8.35MM | $xx.xx | $135.3MM | Canaan Partners, Samsung, Social Capital, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,130,876
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Samsung, Social Capital, Yogen Dalal
|
||||||
09/17/2016 | Series C | $8.35MM | $xx.xx | $135.3MM | Canaan Partners, Samsung, Social Capital, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,130,876
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Samsung, Social Capital, Yogen Dalal
|
||||||
03/17/2015 | Series B-Prime | $8.25MM | $xx.xx | $85.02MM | Canaan Partners, Medtronic, Samsung, Social Capital | |
Price per Share
$xx.xx
Shares Outstanding
6,061,808
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Medtronic, Samsung, Social Capital
|
||||||
03/17/2015 | Series B | $8.25MM | $xx.xx | $85.02MM | Canaan Partners, Medtronic, Samsung, Social Capital | |
Price per Share
$xx.xx
Shares Outstanding
6,061,808
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Medtronic, Samsung, Social Capital
|
||||||
01/08/2014 | Series A-1-Prime | $3.5MM | $xx.xx | $25.22MM | Lifeforce Ventures, Samsung, Social Capital, Sundeep Madra, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,504,968
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Lifeforce Ventures, Samsung, Social Capital, Sundeep Madra, Yogen Dalal
|
||||||
01/08/2014 | Series A-1 | $3.5MM | $xx.xx | $25.22MM | Lifeforce Ventures, Samsung, Social Capital, Sundeep Madra, Yogen Dalal | |
Price per Share
$xx.xx
Shares Outstanding
4,504,968
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Lifeforce Ventures, Samsung, Social Capital, Sundeep Madra, Yogen Dalal
|
||||||
01/30/2012 | Series A-Prime | $1.15MM | $xx.xx | $29.2MM | Andy Hertzfeld, Bill Campbell, Judy Estrin, Russell Hirsch, Social Capital, Venky Harinarayan, Vint Cerf, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
115,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
5.6x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andy Hertzfeld, Bill Campbell, Judy Estrin, Russell Hirsch, Social Capital, Venky Harinarayan, Vint Cerf, Xtreme Labs
|
||||||
01/30/2012 | Series A | $1.15MM | $xx.xx | $29.2MM | Andy Hertzfeld, Bill Campbell, Judy Estrin, Russell Hirsch, Social Capital, Venky Harinarayan, Vint Cerf, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
115,000
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
5.6x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andy Hertzfeld, Bill Campbell, Judy Estrin, Russell Hirsch, Social Capital, Venky Harinarayan, Vint Cerf, Xtreme Labs
|
||||||
11/09/2011 | Series Seed-Prime | $500,000.00 | $xx.xx | $5MM | Anand Agarawala, Andy Hertzfeld, Bill Campbell, Judy Estrin, Russel Hirsch, Social Capital, Venky Harinarayan and Annad Rajaraman, Vint Cerf, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
250,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
2.0x
Conversion Ratio
2.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Anand Agarawala, Andy Hertzfeld, Bill Campbell, Judy Estrin, Russel Hirsch, Social Capital, Venky Harinarayan and Annad Rajaraman, Vint Cerf, Xtreme Labs
|
||||||
11/09/2011 | Series Seed | $500,000.00 | $xx.xx | $5MM | Anand Agarawala, Andy Hertzfeld, Bill Campbell, Judy Estrin, Russel Hirsch, Social Capital, Venky Harinarayan and Annad Rajaraman, Vint Cerf, Xtreme Labs | |
Price per Share
$xx.xx
Shares Outstanding
250,000
Liquidation Pref Order
8
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Anand Agarawala, Andy Hertzfeld, Bill Campbell, Judy Estrin, Russel Hirsch, Social Capital, Venky Harinarayan and Annad Rajaraman, Vint Cerf, Xtreme Labs
|